EV/EBITDA
-0.55
-0.04-7.84%
Sat, 04 Jan 2025 00:40:32 GMT
Summary:
Acurx Pharmaceuticals EV/EBITDA is currently -0.55, with a fall of -0.04 (-7.84%) during the most recent trading day. Over the past year, it has increased by +2.99 (+84.46%). ACXP EV/EBITDA is now -25.00% below its all-time high of -0.44.ACXP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACXP EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -7.8% |
| 1 m1 month | +12.7% |
| 3 m3 months | +69.8% |
| 6 m6 months | +64.3% |
| ytdytd | -17.0% |
| 1 y1 year | +84.5% |
| 5 y5 years | - |
ACXP EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.44 | -25.0% | -0.63 | +12.7% |
| 3 m | 3 months | -0.44 | -25.0% | -1.91 | +71.2% |
| 6 m | 6 months | -0.44 | -25.0% | -2.14 | +74.3% |
| 1 y | 1 year | -0.44 | -25.0% | -4.31 | +87.2% |
| 3 y | 3 years | -0.44 | -25.0% | -5.94 | +90.7% |
| 5 y | 5 years | -0.44 | -25.0% | -15.16 | +96.4% |
| alltime | all time | -0.44 | -25.0% | -15.16 | +96.4% |
Acurx Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.55(+17.0%) |
| 2024 | -0.47(-86.0%) |
| Date | Value |
|---|---|
| 2023 | -3.36(+9.4%) |
| 2022 | -3.07(+26.3%) |
| 2021 | -2.43 |
FAQ
- What is Acurx Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Acurx Pharmaceuticals?
- What is ACXP EV/EBITDA year-to-date change?
- What is Acurx Pharmaceuticals EV/EBITDA year-on-year change?
What is Acurx Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of ACXP is -0.55
What is the all time high EV/EBITDA for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high EV/EBITDA is -0.44
What is ACXP EV/EBITDA year-to-date change?
Acurx Pharmaceuticals EV/EBITDA has changed by -0.08 (-17.02%) since the beginning of the year
What is Acurx Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, ACXP EV/EBITDA has changed by +2.99 (+84.46%)